Canada Life Portfolio holdings
AUM $63.1B
1-Year Return
22.24%
This Quarter Return
+7.8%
1 Year Return
+22.24%
3 Year Return
+92.16%
5 Year Return
+162.31%
10 Year Return
+335.82%
AUM
$46B
AUM Growth
+$3.76B
(+8.9%)
Cap. Flow
+$1.36B
Cap. Flow
% of AUM
2.95%
Top 10 Holdings %
Top 10 Hldgs %
15.96%
Holding
2,794
New
1,683
Increased
565
Reduced
451
Closed
36
Top Buys
| 1 |
Alibaba
BABA
|
+$92M |
| 2 |
Manulife Financial
MFC
|
+$64.7M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$55.7M |
| 4 |
Visa
V
|
+$51.4M |
| 5 |
Colgate-Palmolive
CL
|
+$48.6M |
Top Sells
| 1 |
Apple
AAPL
|
+$189M |
| 2 |
Johnson Controls International
JCI
|
+$132M |
| 3 |
Johnson & Johnson
JNJ
|
+$121M |
| 4 |
Steris
STE
|
+$98.7M |
| 5 |
CELG
Celgene Corp
CELG
|
+$71.4M |
Sector Composition
| 1 | Financials | 21% |
| 2 | Technology | 16.39% |
| 3 | Healthcare | 10.14% |
| 4 | Consumer Discretionary | 9.18% |
| 5 | Communication Services | 8.47% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1951
Amicus Therapeutics
FOLD
$2.47B
| $175K | ﹤0.01% |
18,086
+4,450
| +33% | +$43.1K |
|
1952
Liquidity Services
LQDT
$876M
| $175K | ﹤0.01% |
29,652
| – | – |
|
1953
Amcor
AMCR
$19.3B
| $174K | ﹤0.01% |
16,076
-223,876
| -93% | -$2.42M |
|
|
ACRE
1954
Ares Commercial Real Estate
ACRE
$263M
| $171K | ﹤0.01% |
10,920
+9,749
| +833% | +$153K |
|
1955
Eldorado Gold
EGO
$5.54B
| $171K | ﹤0.01% |
21,334
+3,558
| +20% | +$28.5K |
|
1956
Taylor Morrison
TMHC
$6.75B
| $171K | ﹤0.01% |
+7,857
| New | +$171K |
|
|
AKRX
1957
DELISTED
Akorn, Inc.
AKRX
| $171K | ﹤0.01% |
+115,736
| New | +$171K |
|
1958
Barings BDC
BBDC
$961M
| $169K | ﹤0.01% |
+16,581
| New | +$169K |
|
1959
Ring Energy
REI
$219M
| $169K | ﹤0.01% |
+65,007
| New | +$169K |
|
1960
Willis Towers Watson
WTW
$32.3B
| $168K | ﹤0.01% |
841
-109,771
| -99% | -$21.9M |
|
|
CLDR
1961
DELISTED
Cloudera, Inc.
CLDR
| $168K | ﹤0.01% |
+14,560
| New | +$168K |
|
1962
Houlihan Lokey
HLI
$14.3B
| $167K | ﹤0.01% |
+3,440
| New | +$167K |
|
1963
Steelcase
SCS
$1.94B
| $167K | ﹤0.01% |
+8,229
| New | +$167K |
|
1964
WESCO International
WCC
$10.5B
| $167K | ﹤0.01% |
+2,830
| New | +$167K |
|
1965
Newmark Group
NMRK
$3.33B
| $166K | ﹤0.01% |
+12,419
| New | +$166K |
|
1966
PTC Therapeutics
PTCT
$4.74B
| $166K | ﹤0.01% |
+3,493
| New | +$166K |
|
1967
Axsome Therapeutics
AXSM
$5.69B
| $165K | ﹤0.01% |
+1,610
| New | +$165K |
|
|
XLRN
1968
DELISTED
Acceleron Pharma Inc.
XLRN
| $164K | ﹤0.01% |
+3,114
| New | +$164K |
|
1969
BGC Group
BGC
$4.63B
| $163K | ﹤0.01% |
+27,805
| New | +$163K |
|
1970
Enphase Energy
ENPH
$5.1B
| $163K | ﹤0.01% |
+6,295
| New | +$163K |
|
1971
OR Royalties Inc.
OR
$6.62B
| $163K | ﹤0.01% |
16,912
+1,855
| +12% | +$17.9K |
|
|
APHA
1972
DELISTED
Aphria Inc. Common Shares
APHA
| $160K | ﹤0.01% |
31,056
+26
| +0.1% | +$134 |
|
1973
Moelis & Co
MC
$5.51B
| $159K | ﹤0.01% |
+5,011
| New | +$159K |
|
1974
Ultragenyx Pharmaceutical
RARE
$2.84B
| $159K | ﹤0.01% |
+3,759
| New | +$159K |
|
1975
Simply Good Foods
SMPL
$2.71B
| $159K | ﹤0.01% |
+5,623
| New | +$159K |
|